NCT01492283View on ClinicalTrials.gov

Pathophysiological Implications of the Incretin Hormones in Patients With Liver Disease With and Without Diabetes

CompletedOBSERVATIONAL
Enrollment

48

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

May 31, 2013

Study Completion Date

July 31, 2014

Conditions
Non Alcoholic Fatty Liver DiseaseType 2 DiabetesLiver Cirrhosis
Interventions
OTHER

OGTT

50g waterfree glucose dissolved in 300 ml water consumed over 5 min.

OTHER

IIGI

iso glycemic intravenous (iv) glucose infusion (IIGI) with 20% glucose

Trial Locations (1)

2900

Diabetes Research Division, Gentofte University Hospital, Niels Andersens Vej 65, opgang 4b, 1. sal, Hellerup

All Listed Sponsors
lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT01492283 - Pathophysiological Implications of the Incretin Hormones in Patients With Liver Disease With and Without Diabetes | Biotech Hunter | Biotech Hunter